Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use

Tamara Rushovich; Annika Gompers; Jeffrey W Lockhart; Ife Omidiran; Steven Worthington; Sarah S Richardson; Katharine M N Lee

doi:10.1001/jamanetworkopen.2023.29074

Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use

JAMA Netw Open. 2023 Aug 1;6(8):e2329074. doi: 10.1001/jamanetworkopen.2023.29074.

Authors

Tamara Rushovich¹, Annika Gompers², Jeffrey W Lockhart³, Ife Omidiran⁴, Steven Worthington⁵, Sarah S Richardson⁴, Katharine M N Lee⁶

Affiliations

¹ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
² Emory University Rollins School of Public Health, Atlanta, Georgia.
³ Department of Sociology, University of Chicago, Chicago, Illinois.
⁴ Harvard University, Cambridge, Massachusetts.
⁵ Institute for Quantitative Social Science, Harvard University, Cambridge, Massachusetts.
⁶ Tulane University, New Orleans, Louisiana.

No abstract available

Plain language summary

This cross-sectional study examines adverse drug events reported by sex in the US Food and Drug Administration (FDA) database after adjusting for drug use by males and females.

MeSH terms

Drug-Related Side Effects and Adverse Reactions* / epidemiology
Humans
Substance-Related Disorders* / epidemiology